Mitogen-induced defective mitosis transforms neural progenitor cells

Hiba K Omairi1, Cameron J Grisdale2, Mathieu Meode1

  • 1Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.

Neuro-Oncology
|May 15, 2023
PubMed
Abstract

Insights

Platelet-derived growth factor-A (PDGFA) causes defective mitosis in neural progenitor cells (NPCs), leading to genomic instability and glioblastoma (GBM) development, particularly in P53-deficient cells.

Area of Science:

  • Neuroscience
  • Cancer Biology
  • Genetics

Background:

  • Chromosome instability (CIN) is common in glioblastoma (GBM) but underlying causes are unclear.
  • Genes regulating cell division are rarely mutated in cancers.
  • Platelet-derived growth factor-A (PDGFA), a brain mitogen, was investigated for its role in GBM initiation.

Purpose of the Study:

  • To investigate the effects of PDGFA on neural progenitor cells (NPCs) as a model for GBM initiation.
  • To understand how PDGFA influences mitosis, gene expression, and genomic stability in NPCs.

Main Methods:

  • Utilized an in vitro model of high-grade glioma initiation from murine NPCs.
  • Exposed NPCs to PDGFA and analyzed nuclear/mitotic phenotypes, gene, and protein expression.
  • Assessed P53-dependent effects on mitosis and cell survival.

Main Results:

  • PDGFA induced abnormal mitosis in NPCs, with P53-dependent outcomes.
  • Defective mitosis led to cell death in wild-type cells but was tolerated in P53-null cells.
  • Surviving P53-null cells accumulated chromosomal rearrangements, forming tumorigenic NPCs with GBM-like genomic alterations.

Conclusions:

  • PDGFA can transform NPCs by causing defective mitosis and genomic instability, particularly in the absence of P53.
  • The genomic architecture of GBM may be an adaptation to ensure survival despite mitotic errors.
  • This study reveals a mechanism for NPC transformation by a brain-associated mitogen, offering insights into GBM pathogenesis.